Evgeny Klyuchnikov

1.9k total citations
57 papers, 715 citations indexed

About

Evgeny Klyuchnikov is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Evgeny Klyuchnikov has authored 57 papers receiving a total of 715 indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Hematology, 19 papers in Genetics and 11 papers in Oncology. Recurrent topics in Evgeny Klyuchnikov's work include Hematopoietic Stem Cell Transplantation (27 papers), Acute Myeloid Leukemia Research (22 papers) and Chronic Myeloid Leukemia Treatments (18 papers). Evgeny Klyuchnikov is often cited by papers focused on Hematopoietic Stem Cell Transplantation (27 papers), Acute Myeloid Leukemia Research (22 papers) and Chronic Myeloid Leukemia Treatments (18 papers). Evgeny Klyuchnikov collaborates with scholars based in Germany, Russia and Switzerland. Evgeny Klyuchnikov's co-authors include Nicolaus Kröger, Ulrike Bacher, Francis Ayuk, Christine Wolschke, Axel R. Zander, Tatjana Zabelina, Anita Badbaran, Nico Gagelmann, Maximilian Christopeit and Haefaa Alchalby and has published in prestigious journals such as New England Journal of Medicine, Blood and Frontiers in Immunology.

In The Last Decade

Evgeny Klyuchnikov

49 papers receiving 709 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Evgeny Klyuchnikov Germany 15 615 203 183 176 149 57 715
Thomas Stübig Germany 15 573 0.9× 242 1.2× 268 1.5× 197 1.1× 177 1.2× 25 792
Simona Geroldi Italy 8 640 1.0× 167 0.8× 85 0.5× 240 1.4× 213 1.4× 8 728
Wendy Ingram United Kingdom 13 608 1.0× 191 0.9× 130 0.7× 163 0.9× 345 2.3× 27 864
Ed Kanfer United Kingdom 12 657 1.1× 175 0.9× 70 0.4× 241 1.4× 257 1.7× 19 753
Hirotoshi Sakaguchi Japan 13 442 0.7× 204 1.0× 312 1.7× 65 0.4× 108 0.7× 51 752
EM Bryant United States 11 435 0.7× 118 0.6× 135 0.7× 144 0.8× 234 1.6× 16 675
Hikaru Kobayashi Japan 12 300 0.5× 124 0.6× 153 0.8× 132 0.8× 162 1.1× 24 560
Rudolf Peceny Germany 13 587 1.0× 159 0.8× 153 0.8× 108 0.6× 358 2.4× 20 822
AH Elmaagacli Germany 13 413 0.7× 156 0.8× 90 0.5× 95 0.5× 66 0.4× 15 531
Maël Heiblig France 14 278 0.5× 410 2.0× 130 0.7× 148 0.8× 66 0.4× 75 789

Countries citing papers authored by Evgeny Klyuchnikov

Since Specialization
Citations

This map shows the geographic impact of Evgeny Klyuchnikov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evgeny Klyuchnikov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evgeny Klyuchnikov more than expected).

Fields of papers citing papers by Evgeny Klyuchnikov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evgeny Klyuchnikov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evgeny Klyuchnikov. The network helps show where Evgeny Klyuchnikov may publish in the future.

Co-authorship network of co-authors of Evgeny Klyuchnikov

This figure shows the co-authorship network connecting the top 25 collaborators of Evgeny Klyuchnikov. A scholar is included among the top collaborators of Evgeny Klyuchnikov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evgeny Klyuchnikov. Evgeny Klyuchnikov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Steiner, Normann, Evgeny Klyuchnikov, Anita Badbaran, et al.. (2024). Impact of TP53 Mutation on Outcome after Allogeneic Stem Cell Transplantation for Patients with MDS/AML Not in Complete Remission. Blood. 144(Supplement 1). 3571–3571. 1 indexed citations
4.
Massoud, Radwan, Evgeny Klyuchnikov, Normann Steiner, et al.. (2024). Sequential Conditioning With FLAMSA Does Not Improve Outcomes of Allogeneic Stem Cell Transplantation in Chronic Myelomonocytic Leukemia Patients. Transplantation and Cellular Therapy. 31(1). 20.e1–20.e14. 1 indexed citations
5.
Ayuk, Francis, Eva Wagner-Drouet, Daniel Wolff, et al.. (2024). Treatment of newly diagnosed moderate or severe chronic graft-versus-host disease with prednisone and everolimus (PredEver first): a prospective multicenter phase IIA study. Bone Marrow Transplantation. 59(8). 1092–1096. 2 indexed citations
6.
Gagelmann, Nico, Christine Wolschke, Anita Badbaran, et al.. (2024). Graft-versus-host disease and impact on relapse in myelofibrosis undergoing hematopoietic stem cell transplantation. Bone Marrow Transplantation. 59(4). 550–557. 8 indexed citations
7.
Massoud, Radwan, Rolf Krause, Evgeny Klyuchnikov, et al.. (2024). Development and Validation of a Concise Objectifiable Risk Evaluation Score for Non-Relapse Mortality after Allogeneic Hematopoietic Stem Cell Transplantation. Cancers. 16(3). 515–515. 1 indexed citations
8.
Massoud, Radwan, Hassan Y. Naim, Evgeny Klyuchnikov, et al.. (2023). Allogeneic hematopoetic stem cell transplant for patients with refractory T‐Cell lymphomas. European Journal Of Haematology. 112(2). 276–285.
9.
Klyuchnikov, Evgeny, Anita Badbaran, Radwan Massoud, et al.. (2022). Post-Transplantation Multicolored Flow Cytometry–Minimal Residual Disease Status on Day 100 Predicts Outcomes for Patients With Refractory Acute Myeloid Leukemia. Transplantation and Cellular Therapy. 28(5). 267.e1–267.e7. 5 indexed citations
10.
11.
Niederwieser, Christian, Еlena V. Morozova, L. S. Zubarovskaya, et al.. (2021). Risk factors for outcome after allogeneic stem cell transplantation in patients with advanced phase CML. Bone Marrow Transplantation. 56(11). 2834–2841. 12 indexed citations
12.
13.
Gagelmann, Nico, Christine Wolschke, Evgeny Klyuchnikov, et al.. (2018). Long-Term Results of Prophylactic Donor Lymphocyte Infusions for Patients with Multiple Myeloma after Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 24(7). 1399–1405. 21 indexed citations
14.
Klyuchnikov, Evgeny, Claudia Langebrake, Holger Rohde, et al.. (2015). Atovaquone for Prophylaxis of Toxoplasmosis after Allogeneic Hematopoietic Stem Cell Transplantation. Acta Haematologica. 134(3). 146–154. 11 indexed citations
15.
Klyuchnikov, Evgeny, Jean El Cheikh, Andreas Sputtek, et al.. (2013). CD34+-Selected Stem Cell Boost without Further Conditioning for Poor Graft Function after Allogeneic Stem Cell Transplantation in Patients with Hematological Malignancies. Biology of Blood and Marrow Transplantation. 20(3). 382–386. 67 indexed citations
16.
Zabelina, Tatjana, Francis Ayuk, Haefaa Alchalby, et al.. (2013). Effective prevention of GVHD using in vivo T-cell depletion with anti-lymphocyte globulin in HLA-identical or -mismatched sibling peripheral blood stem cell transplantation. Bone Marrow Transplantation. 49(1). 126–130. 28 indexed citations
17.
Klyuchnikov, Evgeny, Ernst Holler, Martin Bornhäuser, et al.. (2012). Donor lymphocyte infusions and second transplantation as salvage treatment for relapsed myelofibrosis after reduced‐intensity allografting. British Journal of Haematology. 159(2). 172–181. 37 indexed citations
18.
Klyuchnikov, Evgeny, Nicolaus Kröger, Tatjana Zabelina, et al.. (2010). Chimerism studies with quantitative real-time PCR in stem cell recipients with acute myeloid leukemia. Experimental Hematology. 38(12). 1261–1271. 29 indexed citations
19.
Klyuchnikov, Evgeny, Andreas Sputtek, Michael Lioznov, et al.. (2010). Purification of CD4+ T Cells for Adoptive Immunotherapy after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 17(3). 374–383. 11 indexed citations
20.
Stahl, Tanja, Anita Badbaran, Nicolaus Kröger, et al.. (2010). Minimal residual disease diagnostics in patients with acute myeloid leukemia in the post-transplant period: comparison of peripheral blood and bone marrow analysis. Leukemia & lymphoma. 51(10). 1837–1843. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas Stübig Breakdown of academic impact, for papers by Simona Geroldi Breakdown of academic impact, for papers by Wendy Ingram Breakdown of academic impact, for papers by Ed Kanfer Breakdown of academic impact, for papers by Hirotoshi Sakaguchi Breakdown of academic impact, for papers by EM Bryant Breakdown of academic impact, for papers by Hikaru Kobayashi Breakdown of academic impact, for papers by Rudolf Peceny Breakdown of academic impact, for papers by AH Elmaagacli Breakdown of academic impact, for papers by Maël Heiblig
Rankless by CCL
2026